Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics. [electronic resource]
Producer: 19960730Description: 1798-809 p. digitalISSN:- 0732-183X
- Antibodies, Monoclonal
- Carcinoembryonic Antigen -- blood
- Colorectal Neoplasms -- radiotherapy
- Dose-Response Relationship, Radiation
- Gastrointestinal Neoplasms -- diagnostic imaging
- Humans
- Iodine Radioisotopes -- adverse effects
- Pancreatic Neoplasms -- radiotherapy
- Radioimmunotherapy -- adverse effects
- Radionuclide Imaging
- Radiotherapy Dosage
- Stomach Neoplasms -- radiotherapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.